Literature DB >> 15661808

Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells.

Huiqing Yuan1, Aiyu Gong, Charles Y F Young.   

Abstract

The transactivation function of the human androgen receptor (AR) can be regulated by several coregulators that may be either positive or negative. Ubiquitous transcription factor Sp1 not only regulates the basal expression of the AR but also acts as its coregulator. Our previous study has shown that quercetin, one of the main polyphenols, can effectively inhibit the expression and function of the AR. The present study is to address if quercetin may affect Sp1's action on AR transactivation activity in human prostate adenocarcinoma cell lines, LNCaP and PC-3. First, we showed that indeed in transient transfections Sp1 could enhance transcriptional activity of the AR promoter and of androgen upregulated gene promoters, i.e. the prostate-specific antigen and the hK2 genes. Interestingly, the enhancing activity of Sp1 could be repressed by quercetin. The gel shift and western blot analyses indicated that the specific DNA motif binding activity of Sp1 and its protein levels were not altered by quercetin. However, the state of interaction of Sp1 with the AR treated by quercetin plus androgen was different from that by androgen treatment or none as demonstrated by coimmunoprecipitation experiments and glutathione S-transferase (GST) pull-down assays. Moreover, we showed that quercetin caused changes in post-translational modification of AR protein. The above findings strongly suggest that changes induced by quercetin in post-translational modification of the AR and in states of physical interaction of Sp1 with the AR may be critical for the attenuation of AR's function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661808     DOI: 10.1093/carcin/bgi021

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  23 in total

Review 1.  Mechanisms of combined action of different chemopreventive dietary compounds: a review.

Authors:  Theo M de Kok; Simone G van Breda; Margaret M Manson
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

2.  Preferential induction of G1 arrest in androgen-responsive human prostate cancer cells by androgen receptor signaling antagonists DL3 and antiandrogen bicalutamide.

Authors:  Shan Lu; Zongqin Tan; Matthew Wortman; Shan Lu; Zhongyun Dong
Journal:  Cancer Lett       Date:  2010-08-02       Impact factor: 8.679

3.  Sex-specific patterns and deregulation of endocrine pathways in the gene expression profiles of Bangladeshi adults exposed to arsenic contaminated drinking water.

Authors:  Alexandra Muñoz; Yana Chervona; Megan Hall; Thomas Kluz; Mary V Gamble; Max Costa
Journal:  Toxicol Appl Pharmacol       Date:  2015-03-07       Impact factor: 4.219

4.  Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells.

Authors:  Huiqing Yuan; Charles Y F Young; Yuanyuan Tian; Zhifang Liu; Mengye Zhang; Hongxiang Lou
Journal:  Mol Cell Biochem       Date:  2010-02-11       Impact factor: 3.396

5.  Sesquiterpenoids from myrrh inhibit androgen receptor expression and function in human prostate cancer cells.

Authors:  Xiao-ling Wang; Feng Kong; Tao Shen; Charles Y F Young; Hong-xiang Lou; Hui-qing Yuan
Journal:  Acta Pharmacol Sin       Date:  2011-03       Impact factor: 6.150

6.  Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter.

Authors:  Jae Yeon Chun; Yan Hu; Elaine Pinder; Jianguo Wu; Fengzhi Li; Allen C Gao
Journal:  Mol Cancer Ther       Date:  2007-09       Impact factor: 6.261

7.  Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway.

Authors:  Young-Ho Kim; Dae-Hee Lee; Jae-Hoon Jeong; Zong Sheng Guo; Yong J Lee
Journal:  Biochem Pharmacol       Date:  2008-03-10       Impact factor: 5.858

8.  MDM2 expression and regulation in prostate cancer racial disparity.

Authors:  Guimin Wang; Elnaz F Firoz; Amy Rose; Elen Blochin; Paul Christos; Danuta Pollens; Madhu Mazumdar; William Gerald; Carole Oddoux; Peng Lee; Iman Osman
Journal:  Int J Clin Exp Pathol       Date:  2008-12-04

9.  Retigeric acid B exhibits antitumor activity through suppression of nuclear factor-κB signaling in prostate cancer cells in vitro and in vivo.

Authors:  Yong-Qing Liu; Xiao-Yan Hu; Tao Lu; Yan-Na Cheng; Charles Y F Young; Hui-Qing Yuan; Hong-Xiang Lou
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

10.  Anti-Cancer Effects of Paris Polyphylla Ethanol Extract by Inducing Cancer Cell Apoptosis and Cycle Arrest in Prostate Cancer Cells.

Authors:  Denglu Zhang; Kailin Li; Chao Sun; Guangshang Cao; Yuanfu Qi; Zhaomin Lin; Yanxia Guo; Zhiyong Liu; Yuan Chen; Jiaxin Liu; Guanghui Cheng; Peng Wang; Lu Zhang; Jianye Zhang; Jiliang Wen; Dawei Xu; Feng Kong; Shengtian Zhao
Journal:  Curr Urol       Date:  2018-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.